Anthos Therapeutics, based in Cambridge, has a drug in late-stage clinical trials aimed at preventing strokes and blood clots.

Whether it’s Chinese or Japanese or vegan diner food you’re after, you can find it in this Cambridge neighborhood. Narrowing Central Square’s drinking and dining scene down to just 15 must-try spots ...

The Neon is dependable, economical and you can pretty much drive it on any type of road. I'm still looking for "the" one. Great car, nice styling and fun.

SAN DIEGO—Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), a biotechnology company currently valued at $968 million, recently sold a total of 4,000 shares of the company's ...

Glox Therapeutics will receive up to £500,000 of the fund to accelerate the development of its novel precision antibiotics, helping to address the growing need for effective treatments to overcome ...

is a chartered psychologist and registered psychotherapist specialising in existential and child psychotherapy. He lives in Bristol, UK.

Actual terms vary by lender. Here we are in 2022, and I still drive a 2004 Dodge Neon. This thing just will not quit (yet). People ask why I don't get a new car...why would I want the monthly ...

In recent years, mindfulness and acceptance-based therapies have emerged as crucial tools in our therapeutic toolkit, especially for addressing anxiety, depression, and trauma. Techniques like ...

ML-007 is under clinical development by MapLight therapeutics and currently in Phase I for Alzheimer’s Disease. According to GlobalData, Phase I drugs for Alzheimer’s Disease have a 63% phase ...

After five months of intense competition on Sa Re Ga Ma Pa, Mumbai's Shradha Mishra emerged victorious, with Subhasree Debnath and Ujwal Motiram Gajbhar as runners-up. The finale featured ...

This analysis revealed that 221 biological processes, 82 cellular components, 63 molecular functions, and 36 KEGG pathways were employed to identify three therapeutic candidate genes, including CDC20, ...

HOUSTON and CAMBRIDGE, Mass., Jan. 13 ... for patients with cancer in need of new treatment options, and Decoy Therapeutics, Inc., a privately held preclinical biopharmaceutical company ...